| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.3M | — | +48.6% |
| Cost of Revenue | $2.8M | — | +15.4% |
| Gross Profit | $2.6M | — | +116.1% |
| R&D Expense | $503K | — | -32.0% |
| SG&A Expense | $3.7M | — | +57.5% |
| Operating Income | -$1.6M | — | +14.3% |
| Pre-tax Income | -$1.5M | — | +17.3% |
| Net Income | -$1.5M | — | +17.3% |
| EPS (Basic) | -$0.06 | — | +33.3% |
| EPS (Diluted) | -$0.06 | — | +33.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $11.8M | +137.1% | -30.3% |
| Short-term Investments | $6.6M | — | — |
| Accounts Receivable | $3.8M | +14.2% | +72.0% |
| Inventory | $9.9M | +10.7% | +38.0% |
| Current Assets | $33.2M | +32.4% | +23.8% |
| Total Assets | $59.7M | +16.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.1M | — | -56.3% |
| Capital Expenditures | $361K | — | +0.0% |
| Investing Cash Flow | -$6.6M | — | -1722.5% |
| Financing Cash Flow | $9.8M | — | — |
| Free Cash Flow | -$3.5M | — | -47.8% |
| +42.0% |
| Current Liabilities | $7.8M | -47.6% | +252.3% |
| Total Liabilities | $11.4M | -38.9% | +81.0% |
| Stockholders' Equity | $48.4M | +47.2% | +35.2% |